(Q46763647)

25 December 2017

title

Transformation of MALT lymphoma to pure plasma cell histology following treatment with the anti-CD20 antibody rituximab (English)

1 reference

25 December 2017

1 reference

Stefan Woehrer

1

1 reference

25 December 2017

Berthold Streubel

2

1 reference

25 December 2017

Andreas Chott

3

1 reference

25 December 2017

Martha Hoffmann

4

1 reference

25 December 2017

Markus Raderer

5

1 reference

25 December 2017

publication date

1 November 2005

1 reference

25 December 2017

published in

Leukemia & Lymphoma

1 reference

25 December 2017

volume

46

1 reference

25 December 2017

page(s)

1645-1649

1 reference

25 December 2017

issue

11

1 reference

25 December 2017

The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190500178399

Gastric MALT lymphoma: from concept to cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500178399

21 January 2018

Marginal-zone B cells

1 reference

https://api.crossref.org/works/10.1080%2F10428190500178399

Treatment of alpha chain disease. Results of a prospective study in 21 Tunisian patients by the Tunisian-French intestinal Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500178399

Immunoproliferative small intestinal disease: a study of 13 cases with alpha heavy-chain disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500178399

Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500178399

Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500178399

Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500178399

Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500178399

18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500178399

10.1080/10428190500178399

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

PubMed ID

16236618

1 reference

25 December 2017